DeFi Capital Markets, Inc.: Form 10-Q for the period ended Dec 31, 2024
Filed with the SEC on Feb 14, 2025 and accepted by EDGAR at Feb 14, 2025, 16:30 ET.
Management's discussion and analysis
As filed, 11,431 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
As used throughout this Report, “we,” “our,” “the Company” “USI” and similar words refers to Universal Security Instruments, Inc.
FORWARD-LOOKING STATEMENTS
This Quarterly Report on Form 10-Q contains certain forward-looking statements reflecting our current expectations with respect to our operations, performance, financial condition, and other developments. These forward-looking statements may generally be identified by the use of the words “may”, “will”, “believes”, “should”, “expects”, “anticipates”, “estimates”, and similar expressions. These statements are necessarily estimates reflecting management’s best judgment based upon current information and involve a number of risks and uncertainties. We caution readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made, and readers are advised that various factors could affect our financial performance and could cause our actual results for future periods to differ materially from those anticipated or projected. While it is impossible to identify all such factors, such factors include, but are not limited to, those risks identified in our periodic reports filed with the Securities and Exchange Commission.
OVERVIEW
We are in the business of marketing and distributing safety and security products. Our financial statements detail our sales and other operational results for the three and nine-month periods ended December 31, 2024, and 2023.
The Company has developed products based on new smoke and gas detection technologies, with what the Company believes are improved sensing technology and product features. Most of our new technologies and features have been trademarked under the trade name IoPhic.
Changes in international trade duties and other aspects of international trade policy, both in the U.S. and abroad, could materially impact the cost of our products. All of our products are imported from the Peoples Republic of China (PRC). To date, only certain of our products such as Carbon Monoxide and Photoelectric alarms, and certain wiring devices, have been subjected to tariffs of 25%. We are monitoring these developments and will determine our strategies as additional information becomes available. Any increase in tariffs that is not offset by an increase in our sales prices could have an adverse effect on our business, financial position, results of operations or cash flows.
RESULTS OF OPERATIONS
Three Months Ended December 31, 2024 and 2023
Sales. Net sales for the three months ended December 31, 2024, were $5,535,148 compared to $4,654,978 for the comparable three months in the prior year, an increase of $880,170 (18.9%). Sales increased principally due to the timing of orders from a large retail customer.
Gross Profit Margin. Gross profit margin is calculated as net sales less cost of goods sold expressed as a percentage of net sales. Our gross profit margin was 18.5% and 32.3% of sales for the quarters ended December 31, 2024, and 2023, respectively. Gross margins for the three-month period ended December 31, 2024, decreased principally due to the bulk sale of certain excess and obsolete inventory at reduced gross profit margins. In addition, gross margins in the current and prior comparable three-month periods were impacted by variations in the mix of products sold.
Expenses. Selling, general and administrative expenses were $1,762,446 for the three months ended December 31, 2024, compared to $1,310,872 for the comparable three months in the prior year. As a percentage of net sales, these expenses increased to 31.8% for the three-month period ended December 31, 2024, from 28.2% for the 2023 period. These expenses increased as a dollar amount principally due to the timing of expenditures comprised principally of legal, proxy solicitation, proxy tabulation, and consulting business advisors related to efforts in the current quarter to pursue the previously mentioned Asset Purchase Agreement pursuant to which the Company has agreed, subject to shareholder approval, to sell certain inventory and non-tangible assets of the Company, constituting substantially all of the assets of the Company.
Engineering and product development expenses were $130,395 for the three-month period ended December 31, 2024, and $77,295 for the comparable quarter of the prior year, a $53,100 (68.7%) increase. These expenses increased primarily due to an increase in product development costs.
Interest Expense. Our interest expense was $77,409 for the quarter ended December 31, 2024, compared to interest expense of $36,310 for the quarter ended December 31, 2023. Interest expense is dependent upon the total amounts borrowed from the Factor and changes in interest rates during the period as compared to the corresponding period of the prior year.
Net (Loss) Income. We reported a net loss of $936,639 for the quarter ended December 31, 2024, compared to net income of $102,176 for the corresponding quarter of the prior fiscal year, a $1,038,815 decrease in net income. Net income decreased principally due to lower gross profit margins as discussed above and due to expenditures related to efforts in the current quarter to pursue strategic alternatives and merger activities.
Nine Months Ended December 31, 2024 and 2023
Sales. Net sales for the nine months ended December 31, 2024, were $17,336,933 compared to $15,071,204 for the comparable nine months in the prior period, an increase of $2,265,729 (15.0%). Sales increased principally due to the timing of orders to a large retailer, improvements in deliveries of products, and the easing of supply chain disruptions in shipping and handling of containers at California ports of entry. While delays in manufacturing and shipping have improved somewhat over the past fiscal year, we continue to experience delays in receiving inventory for sale.
Gross Profit Margin. The gross profit margin is calculated as net sales less cost of goods sold expressed as a percentage of net sales. The Company’s gross profit margin was 23.7% for the period ended December 31, 2024, and 30.0% for the period ended December 31, 2023. Gross margins for the nine-month period ended December 31, 2024, decreased principally due to an increase in the allowance for excess and obsolete inventory recorded during the nine-month period ended December 31, 2024, and due to the bulk sale of certain excess and obsolete inventory at reduced gross profit margins. In addition, gross margins in the nine-month period decreased due to increases in the cost of certain electronic components and variations in the mix of products sold. Gross margins are also impacted by variations in the mix of products sold and due to continued increases in the cost of certain electronic components.
Expenses. Selling, general and administrative expenses were $4,369,219 for the nine months ended December 31, 2024, compared to $4,068,162 for the comparable nine months in the prior year. As a percentage of sales, these expenses were 25.2% for the nine-month period ended December 31, 2024, and 27.0% for the comparable 2023 period. These expenses increased as a dollar amount principally due to the timing of expenditures related to efforts in the current nine-month period and the comparable period of the prior year to pursue strategic alternatives and merger activities.
Engineering and product development expenses were $328,367 for the nine months ended December 31, 2024, compared to $273,673 for the comparable period of the prior year. These expenses increased primarily due to an increase in product development costs.
Interest Expense. Our interest expense was $211,939 for the nine months ended December 31, 2024, compared to interest expense of $120,315 for the nine months ended December 31, 2023. Net interest income of $24,746 was earned in the nine month period ended December 31, 2023 primarily on refunded customs charges. Interest expense is dependent upon the total amounts borrowed from the Factor and changes in interest rates during the period as compared to the corresponding period of the prior year.
Net (Loss) Income. We reported a net loss of $801,867 for the nine months ended December 31, 2024, compared to net income of $80,881 for the corresponding period of the prior fiscal year, a decrease in net income of $882,748. Net income decreased principally due to lower gross profit margins as discussed above and due to expenditures related to efforts in the nine months ended December 31, 2024, to pursue strategic alternatives and merger activities.
Operating activities used cash of $736,999 for the nine months ended December 31, 2024. This was primarily due to a decrease in accounts receivable and amount due from factor of $32,581, and an increase in accounts payable and accrued expenses of $1,233,487, offset by an increase in inventories and prepaid expenses of $1,505,513, and a net loss of $801,867. Operating activities provided cash of $225,962 for the nine months ended December 31, 2023. This was primarily due to net income of $80,881, a decrease in accounts receivable and amount due from factor of $311,821, and an increase in accounts payable and accrued expenses of $874,648, and offset by an increase in inventories, prepaid expenses of $1,050,814.
There were no investing activities for the nine months ended December 31, 2024, or 2023.
Financing activities provided cash of $730,800 during the nine months ended December 31, 2024, and used cash of $338,286 during the nine months ended December 30, 2023, which is comprised of borrowings from the factor net of repayments.
LIQUIDITY AND CAPITAL RESOURCES
During the nine-month period ending December 31, 2024, the Company recorded a net loss of $801,867 and used cash of $736,999 in operating activities. Approximately $435,000 of the loss from operations is related to costs incurred in furtherance of the proposed sale of the operating assets of the Company in accordance with the Asset Purchase Agreement noted above. These expenditures used significant cash and have negatively impacted the Company’s availability of cash advances under its factoring agreement. The Company has previously disclosed that it has limited financial resources and access to capital. Financing is limited to amounts available under the factoring agreement as previously discussed. The uncertainty associated with the recurring operating losses, and limited financial resources and access to capital, raise substantial doubt about our ability to continue as a going concern for at least one-year after the date the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q are issued.
CRITICAL ACCOUNTING POLICIES
In the notes to the consolidated financial statements, and in “Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations” included in our Form 10-K, we have disclosed those accounting policies that we consider to be significant in determining our results of Operations and financial condition. There have been no material changes to those policies that we consider to be significant since the filing of our Form 10-K. The accounting principles used in preparing our unaudited condensed consolidated financial statements conform in all material respects to accounting principles generally accepted in the United States of America.
Controls and procedures
As filed, 2,375 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
We maintain a system of disclosure controls and procedures (as such item is defined in Rules 13a – 15(e) and 15d – 15(e) of the Exchange Act) that is designed to provide reasonable assurance that information, which is required to be disclosed by us in the reports that we file or submit under the Securities and Exchange Act of 1934, as amended, is recorded, processed, summarized and reported within the time periods specified in the rules and forms of the Securities and Exchange Commission, and is accumulated and communicated to management in a timely manner. Our Chief Executive Officer and Chief Financial Officer have evaluated this system of disclosure controls and procedures in accordance with applicable Securities and Exchange Commission guidance as of the end of the period covered by this annual report and have concluded that disclosure controls and procedures were not effective.
A material weakness arose during the fiscal years ended March 31, 2024, and 2023, in the management review controls over classification of and disclosure of amounts within the financial statements. In remediation thereof, the Company now requires the concurrence of two members of management in its review of the classification of, and disclosure of amounts within the financial statements.
A material weakness arose during the fiscal years ended March 31, 2024, and 2023, in the management review controls over the classification of and accounting for income taxes. In remediation thereof, the Company now requires the concurrence of two members of management in its review and control over its classification and accounting for income taxes.
A material weakness arose during the fiscal year ended March 31, 2024, in management’s review and control over documentation supporting entries posted to the Company’s general ledger. In remediation thereof, the Company now requires the concurrence of two members of management in its review and control over documentation supporting entries posted to the Company’s general ledger.
Changes in Internal Control over Financial Reporting
There have been no other changes in internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, internal control over financial reporting during the quarter ended December 31, 2024.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-10-01 to 2024-12-31 | $5.5m | us-gaap:Revenues |
| Revenue | 9 months2024-04-01 to 2024-12-31 | $17.3m | us-gaap:Revenues |
| Cost of revenue | 3 months2024-10-01 to 2024-12-31 | $4.5m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2024-04-01 to 2024-12-31 | $13.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-10-01 to 2024-12-31 | $1.0m | us-gaap:GrossProfit |
| Gross profit | 9 months2024-04-01 to 2024-12-31 | $4.1m | us-gaap:GrossProfit |
| Selling, general and administrative | 3 months2024-10-01 to 2024-12-31 | $1.8m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2024-04-01 to 2024-12-31 | $4.4m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2024-10-01 to 2024-12-31 | −$870.8k | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2024-04-01 to 2024-12-31 | −$589.9k | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2024-10-01 to 2024-12-31 | $77.4k | us-gaap:InterestExpense |
| Interest expense | 9 months2024-04-01 to 2024-12-31 | $211.9k | us-gaap:InterestExpense |
| Income tax | 3 months2024-10-01 to 2024-12-31 | −$11.6k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-10-01 to 2024-12-31 | −$936.6k | us-gaap:NetIncomeLoss |
| Net income | 9 months2024-04-01 to 2024-12-31 | −$801.9k | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-10-01 to 2024-12-31 | −$0.40 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2024-04-01 to 2024-12-31 | −$0.35 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-10-01 to 2024-12-31 | −$0.40 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2024-04-01 to 2024-12-31 | −$0.35 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-10-01 to 2024-12-31 | 2,312,887 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2024-04-01 to 2024-12-31 | 2,312,887 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2024-04-01 to 2024-12-31 | −$737.0k | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2024-12-31 | $58.9k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-12-31 | $9.5m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-12-31 | $9.6m | us-gaap:Assets |
| Current liabilities | At period end2024-12-31 | $5.4m | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2024-12-31 | $4.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001410578-25-000141. Last ingested by Listed: Nov 4, 2026, 06:09 ET. Listed shows no prices and gives no investment advice.